Literature DB >> 16191330

[Progress in research of strabismus and amblyopia in China in the new century].

Kan-xing Zhao1, Xue-feng Shi.   

Abstract

In the last 5 years, we witnessed the progress in the basic and clinical research of strabismus and amblyopia in China, which should be attributed to the effective leadership of the Chinese Ophthalmological Society and the efforts of all members of the professional team. We are glad to see the work of our researchers and clinical scientists in the studies on the molecular and neuronal mechanisms of amblyopia, visual developmental plasticity and functional brain imaging of amblyopia, in the studies on the extraocular muscle's pulley and in the studies on the diagnoses and therapies of strabismus and amblyopia, and furthermore, in epidemiological studies of strabismus and amblyopia. We expect more fruits and creative findings in this field in China in the next decade.

Entities:  

Mesh:

Year:  2005        PMID: 16191330

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  4 in total

1.  Influences of levodopa on expression of N-methyl-D-aspartate receptor-1-subunit in the visual cortex of monocular deprivation rats.

Authors:  Xiao-Nan Sun; Jin-Song Zhang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

2.  Scientometric analysis of published papers in global ophthalmology in the past ten years.

Authors:  Zheng-Lu Yu; Xin-Yue Hu; Ying-Na Wang; Zheng Ma
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

Review 3.  Exotropia Is the Main Pattern of Childhood Strabismus Surgery in the South of China: A Six-Year Clinical Review.

Authors:  Xinping Yu; Zhouduo Ji; Huanyun Yu; Meiping Xu; Jinling Xu
Journal:  J Ophthalmol       Date:  2016-02-28       Impact factor: 1.909

Review 4.  Pharmacological therapy for amblyopia.

Authors:  Anupam Singh; Ritu Nagpal; Sanjeev Kumar Mittal; Chirag Bahuguna; Prashant Kumar
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.